The Medicrea Group reported its sales for the first half of 2017.
Here are eight things to know:
1. The company saw sales totaling $16.75 million for the first half of the year.
2. In the U.S., sales increased 10 percent in the first half of 2017 compared to the first half of 2016.
3. In France, company sales saw an 8 percent jump in the first half of 2017 compared to the first half of 2016.
4. Medicrea faced local economic and regulatory obstacles in Brazil, which yielded a 63 percent dip in sales in the first half of 2017 compared to the same period the year prior.
5. In the U.S. Medicrea's UNiD ASI systems technology revenue saw a 41 percent jump in the first half of 2017, compared to the first half of 2016.
6. The company's UNiD TEK and associated implants raked in more than $15 million in the U.S. for the first half of 2017. The UNiD Rod used with the PASS spinal systems especially saw growth.
7. Surgeons performed more than 1,500 UNiD ASI surgeries globally in the first half of 2017. Medicrea reported a record number of used UNiD TEK, patient-specific implants in June.
8. Additionally, the company boasts the first personalized minimally invasive spine surgery in the U.S. with its UNiD MIS Rod.